Myriad Genetics Presents at BofA and Goldman Sachs Healthcare Conferences
Myriad Genetics (NASDAQ: MYGN), a molecular diagnostic testing and precision medicine company,...
presents
Women’s health presents untapped investment opportunities
Innovation and start-up activity in women’s healthtech is increasing at an astounding rate. These start-ups, more and more which are...
